413 related articles for article (PubMed ID: 30306695)
1. The effect of antiresorptive drugs on implant therapy: Systematic review and meta-analysis.
Stavropoulos A; Bertl K; Pietschmann P; Pandis N; Schiødt M; Klinge B
Clin Oral Implants Res; 2018 Oct; 29 Suppl 18():54-92. PubMed ID: 30306695
[TBL] [Abstract][Full Text] [Related]
2. Is it safe to place implants in patients at risk of MRONJ?
Owen B; Bradley H
Evid Based Dent; 2021 Jan; 22(3):108-109. PubMed ID: 34561663
[TBL] [Abstract][Full Text] [Related]
3. Oral implant survival in patients with bisphosphonate (BP)/antiresorptive and radiation therapy and their impact on osteonecrosis of the jaws. A systematic review.
Schmitt CM; Buchbender M; Lutz R; Neukam FW
Eur J Oral Implantol; 2018; 11 Suppl 1():S93-S111. PubMed ID: 30109302
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Radiographic Outcomes of Dental Implants in Patients Treated With Antiresorptive Drugs: A Consecutive Case Series.
Otto S; Schnoedt EM; Troeltzsch M; Kaeppler G; Aljohani S; Liebermann A; Fliefel R
J Oral Implantol; 2023 Feb; 49(1):39-45. PubMed ID: 35446931
[TBL] [Abstract][Full Text] [Related]
5. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review.
Madrid C; Sanz M
Clin Oral Implants Res; 2009 Sep; 20 Suppl 4():87-95. PubMed ID: 19663954
[TBL] [Abstract][Full Text] [Related]
6. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
7. Dental Implant Placement in Patients With a History of Medications Related to Osteonecrosis of the Jaws: A Systematic Review.
Sher J; Kirkham-Ali K; Luo JD; Miller C; Sharma D
J Oral Implantol; 2021 Jun; 47(3):249-268. PubMed ID: 32699903
[TBL] [Abstract][Full Text] [Related]
8. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
9. Group 3 ITI Consensus Report: Materials and antiresorptive drug-associated outcomes in implant dentistry.
Al-Nawas B; Lambert F; Andersen SWM; Bornstein MM; Gahlert M; Jokstad A; Jung J; Kwon YD; Laleman I; Oteri G; Roehling S; Schiegnitz E; Takeda Y; Terheyden H
Clin Oral Implants Res; 2023 Sep; 34 Suppl 26():169-176. PubMed ID: 37750518
[TBL] [Abstract][Full Text] [Related]
10. What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis.
Ata-Ali J; Ata-Ali F; Peñarrocha-Oltra D; Galindo-Moreno P
Clin Oral Implants Res; 2016 Feb; 27(2):e38-46. PubMed ID: 25406770
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis.
Srivastava A; Nogueras Gonzalez GM; Geng Y; Won AM; Cabanillas ME; Naing A; Myers JN; Li Y; Chambers MS
Support Care Cancer; 2021 May; 29(5):2305-2317. PubMed ID: 33190182
[TBL] [Abstract][Full Text] [Related]
12. Clinical Impact on Dental Implant Survival in Patients Taking Antiresorptive Medications: A Systematic Review and Meta-Analysis.
Ting M; Huynh BH; Woldu HG; Gamal I; Suzuki JB
J Oral Implantol; 2023 Dec; 49(6):599-615. PubMed ID: 37905745
[TBL] [Abstract][Full Text] [Related]
13. What is the effect of anti-resorptive drugs (ARDs) on the development of medication-related osteonecrosis of the jaw (MRONJ) in osteoporosis patients: A systematic review.
Aljohani S; Fliefel R; Ihbe J; Kühnisch J; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1493-1502. PubMed ID: 28687467
[TBL] [Abstract][Full Text] [Related]
14. Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?
Troeltzsch M; Cagna D; Stähler P; Probst F; Kaeppler G; Troeltzsch M; Ehrenfeld M; Otto S
J Craniomaxillofac Surg; 2016 Dec; 44(12):1945-1951. PubMed ID: 27836551
[TBL] [Abstract][Full Text] [Related]
15. Drugs and diseases: Summary and consensus statements of group 1. The 5
Schliephake H; Sicilia A; Nawas BA; Donos N; Gruber R; Jepsen S; Milinkovic I; Mombelli A; Navarro JM; Quirynen M; Rocchietta I; Schiødt M; Schou S; Stähli A; Stavropoulos A
Clin Oral Implants Res; 2018 Oct; 29 Suppl 18():93-99. PubMed ID: 30306683
[TBL] [Abstract][Full Text] [Related]
16. Effect of advanced age and/or systemic medical conditions on dental implant survival: A systematic review and meta-analysis.
Schimmel M; Srinivasan M; McKenna G; Müller F
Clin Oral Implants Res; 2018 Oct; 29 Suppl 16():311-330. PubMed ID: 30328186
[TBL] [Abstract][Full Text] [Related]
17. Survival of dental implants among post-menopausal female dental school patients taking oral bisphosphonates: a retrospective study.
Famili P; Quigley S; Mosher T
Compend Contin Educ Dent; 2011; 32(6):E106-9. PubMed ID: 23738968
[TBL] [Abstract][Full Text] [Related]
18. Osseointegration of dental implants in patients undergoing bisphosphonate treatment: a literature review.
Javed F; Almas K
J Periodontol; 2010 Apr; 81(4):479-84. PubMed ID: 20367090
[TBL] [Abstract][Full Text] [Related]
19. Is medication related osteonecrosis of the jaw around implants a rare entity? A case series with a focus on etiopathophysiology.
Massaad J; Magremanne M
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e743-e748. PubMed ID: 34922047
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases.
Grant BT; Amenedo C; Freeman K; Kraut RA
J Oral Maxillofac Surg; 2008 Feb; 66(2):223-30. PubMed ID: 18201600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
